This Article Full Text Full Text (PDF) All Versions of this Article: biophysj.107.114090v1 94/7/2667    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Deleu, M. Articles by Nylander, T. Search for Related Content PubMed PubMed Citation Articles by Deleu, M. Articles by Nylander, T.

Effect of Fengycin, a Lipopeptide Produced by Bacillus subtilis, on Model Biomembranes

Magali Deleu ^*, Michel Paquot ^* and Tommy Nylander 

^* Unité de Chimie biologique industrielle, Faculté universitaire des Sciences agronomiques de Gembloux, B-5030 Gembloux, Belgium; and Physical Chemistry 1, Lund University, Center for Chemistry and Chemical Engineering, S-221 00 Lund, Sweden

Correspondence: Address reprint requests to Magali Deleu, Tel.: 32-81-62-22-32; Fax: 32-81-62-22-31; E-mail: deleu.m{at}fsagx.ac.be.

Fengycin is a biologically active lipopeptide produced by several Bacillus subtilis strains. The lipopeptide is known to develop antifungal activity against filamentous fungi and to have hemolytic activity 40-fold lower than that of surfactin, another lipopeptide produced by B. subtilis. The aim of this work is to use complementary biophysical techniques to reveal the mechanism of membrane perturbation by fengycin. These include: 1), the Langmuir trough technique in combination with Brewster angle microscopy to study the lipopeptide penetration into monolayers; 2), ellipsometry to investigate the adsorption of fengycin onto supported lipid bilayers; 3), differential scanning calorimetry to determine the thermotropic properties of lipid bilayers in the presence of fengycin; and 4), cryogenic transmission electron microscopy, which provides information on the structural organization of the lipid/lipopeptide system. From these experiments, the mechanism of fengycin action appears to be based on a two-state transition controlled by the lipopeptide concentration. One state is the monomeric, not deeply anchored and nonperturbing lipopeptide, and the other state is a buried, aggregated form, which is responsible for membrane leakage and bioactivity. The mechanism, thus, appears to be driven mainly by the physicochemical properties of the lipopeptide, i.e., its amphiphilic character and affinity for lipid bilayers.